Novartis Eye Drug Suffers Fresh Rebuff In Britain | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Thursday, November 24, 2011

Reuters

Novartis's costly eye drug Lucentis has been rejected for another new use by NICE, following a similar setback in July.

Which of the following is NOT a treatment for corneal ectasia?
1. Intacs
2. RGP contact lens
3. Penetrating keratoplasty
4. PRK
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us